| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Business Development Off
1 company
Gano Kyle is a Chief Executive Officer at NEUROCRINE BIOSCIENCES INC. Recent SEC Form 4 filings include 0 buys and 14 sells.
Estimated insider holdings value: $21.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2025 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sale+OE | 300 | $141.97 | $42,591.00 | -0.2% | -3.9% | - | |
| Feb 13, 2025 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sale+OE | 2,558 | $116.85 | $298,908.05 | -0.9% | +1.6% | +6.2% | |
| Feb 10, 2025 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sale+OE | 980 | $118.39 | $116,020.34 | -0.7% | +1.4% | +15.9% | |
| Jan 31, 2025 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sale+OE | 1,541 | $152.87 | $235,577.45 | -1.1% | -29.8% | -10.4% | |
| Jan 15, 2025 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sale+OE | 65,000 | $141.50 | $9,197,549.84 | -19.4% | -32.5% | -6.5% | |
| Feb 13, 2024 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sell | 1,352 | $132.89 | $179,673.63 | -1.0% | +1.7% | -12.4% | |
| Feb 8, 2024 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sell | 2,580 | $139.16 | $359,041.22 | -1.0% | +3.4% | -8.8% | |
| Jan 31, 2024 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sell | 1,541 | $140.70 | $216,812.54 | -1.2% | -1.6% | +9.7% | |
| Jan 2, 2024 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sale+OE | 75,000 | $131.47 | $9,860,194.47 | -22.4% | +7.3% | +4.7% | |
| Aug 21, 2023 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sell | 2,132 | $107.41 | $228,992.79 | -1.6% | +1.0% | +38.1% |